Home LiteratureArticle Details
PMID: 1383385 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain.

The Journal of experimental medicine ·Vol. 176 ·No. 5 ·1992-11-01 ·Pages 1355-64

Khoury SJ, Hancock WW, Weiner HL

Abstract

Experimental autoimmune encephalomyelitis (EAE) in the Lewis rat is a self-limited inflammatory process localized to the central nervous system that is induced by the injection of myelin basic protein (MBP) in adjuvant. Oral administration of MBP suppresses EAE, and this suppression is mediated by CD8+ T cells that adoptively transfer protection and suppress both in vitro and in vivo by the release of transforming growth factor (TGF) beta after antigen-specific triggering. Furthermore, oral tolerance to MBP is enhanced by the concomitant oral administration of lipopolysaccharide (LPS). The present study was undertaken to determine whether the disease course in EAE and its suppression by oral tolerization to MBP is associated with distinct patterns of cytokine expression in the target organ. Detailed immunohistology of the brain was performed at the peak of clinical disease (day 14 after immunization) and after recovery (day 18) in control (ovalbumin [OVA]-fed), MBP-fed, and MBP plus LPS-fed animals. Brains from OVA-fed animals at the peak of disease showed perivascular infiltration with activated mononuclear cells which secreted the inflammatory cytokines interleukins (IL) 1, 2, 6, 8, TNF-alpha, and interferon gamma. The inhibitory cytokines TGF-beta and IL-4, and prostaglandin E2 (PGE2) were absent. In MBP orally tolerized animals there was a marked reduction of the perivascular infiltrate and downregulation of all inflammatory cytokines. In addition, there was upregulation of the inhibitory cytokine TGF-beta. In MBP plus LPS orally tolerized animals, in addition to upregulation of TGF-beta and reduction of inflammatory cytokines, there was enhanced expression of IL-4 and PGE2, presumably secondary to activation of an additional population of immunoregulatory cells. In OVA-fed animals that had recovered (day 18), staining for inflammatory cytokines diminished, and there was the appearance of TGF-beta and IL-4. These results suggest that suppression of EAE, either induced by oral tolerization or that which occurs during natural recovery is related to the secretion of inhibitory cytokines or factors that actively suppress the inflammatory process in the target organ.

MeSH Terms
Animals Brain Chemistry Cytokines/analysis Down-Regulation Encephalomyelitis, Autoimmune, Experimental/immunology,pathology Female Immune Tolerance Interleukin-4/analysis Lipopolysaccharides Myelin Basic Protein/immunology Ovalbumin/immunology Prostaglandins E/analysis Rats Rats, Inbred Lew Transforming Growth Factor beta/analysis Up-Regulation
Chemicals
Cytokines Lipopolysaccharides Myelin Basic Protein Prostaglandins E Transforming Growth Factor beta Interleukin-4 Ovalbumin
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Khoury S J
Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115.
Hancock W W
Weiner H L
References (41)
41 references, click to expand
  1. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides.
    Arthritis Rheum. 1988 Jun;31(6):784-8 PMID: 3260102
  2. Effect of indomethacin treatment upon actively-induced and transferred experimental allergic encephalomyelitis (EAE) in Lewis rats.
    Clin Exp Immunol. 1982 Aug;49(2):386-92 PMID: 6982136
  3. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells.
    J Exp Med. 1984 Aug 1;160(2):618-23 PMID: 6332168
  4. The immunopathology of experimental allergic encephalomyelitis. II. Endothelial cell Ia increases prior to inflammatory cell infiltration.
    J Immunol. 1984 May;132(5):2402-7 PMID: 6425402
  5. Evidence for functional heterogeneity of rat CD4+ T cells in vivo. Differential expression of IL-2 and IL-4 mRNA in recipients of cardiac allografts.
    J Immunol. 1992 Mar 1;148(5):1308-14 PMID: 1347048
  6. Evidence that therapeutic strategies targeted at CD4+ cells modulate accelerated rejection of cardiac allografts in sensitized rats by different mechanisms.
    Transplantation. 1992 Aug;54(2):292-6 PMID: 1353914
  7. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering.
    Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):421-5 PMID: 1370356
  8. Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the rat.
    Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7762-6 PMID: 1502196
  9. CD4+ suppressor cells inhibit the function of effector cells of experimental autoimmune encephalomyelitis through a mechanism involving transforming growth factor-beta.
    J Immunol. 1991 Feb 15;146(4):1163-8 PMID: 1671402
  10. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. III. Synergistic effect of lipopolysaccharide.
    Cell Immunol. 1990 Dec;131(2):302-10 PMID: 1700738
  11. Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1.
    J Immunol. 1991 May 1;146(9):3012-7 PMID: 1707929
  12. Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-beta 1.
    J Immunol. 1991 Sep 15;147(6):1792-6 PMID: 1716279
  13. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig.
    Ann Neurol. 1991 Jun;29(6):615-22 PMID: 1716432
  14. Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy.
    J Immunol. 1991 Oct 1;147(7):2155-63 PMID: 1717550
  15. Antigen-driven bystander suppression after oral administration of antigens.
    J Exp Med. 1991 Oct 1;174(4):791-8 PMID: 1717632
  16. Cytokines in the central nervous system of mice during chronic relapsing experimental allergic encephalomyelitis.
    Cell Immunol. 1991 May;134(2):505-10 PMID: 1902401
  17. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin.
    Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10252-6 PMID: 1946445
  18. Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice.
    Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2918-21 PMID: 2011600
  19. Interleukin-4: a prototypic immunoregulatory lymphokine.
    Blood. 1991 May 1;77(9):1859-70 PMID: 2018830
  20. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis.
    J Immunol. 1991 Jul 1;147(1):117-23 PMID: 2051017
  21. Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen.
    J Immunol. 1990 Oct 15;145(8):2489-93 PMID: 2120332
  22. Biological and clinical aspects of interleukin 6.
    Immunol Today. 1990 Dec;11(12):443-9 PMID: 2127356
  23. Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen.
    J Immunol. 1990 Mar 1;144(5):1689-95 PMID: 2137841
  24. Interleukin 6 production in the central nervous system during experimental autoimmune encephalomyelitis.
    Eur J Immunol. 1990 Jan;20(1):233-5 PMID: 2307176
  25. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.
    J Immunol. 1986 Apr 1;136(7):2348-57 PMID: 2419430
  26. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments.
    J Immunol. 1988 Jan 15;140(2):440-5 PMID: 2447178
  27. Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein.
    Cell Immunol. 1988 Apr 1;112(2):364-70 PMID: 2451570
  28. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. II. Suppression of disease and in vitro immune responses is mediated by antigen-specific CD8+ T lymphocytes.
    J Immunol. 1989 Feb 1;142(3):748-52 PMID: 2464023
  29. Indomethacin augments in vitro proliferative responses of Lewis rat lymphocytes to myelin basic protein. Implications for experimental autoimmune encephalomyelitis.
    Cell Immunol. 1989 Jun;121(1):196-212 PMID: 2470519
  30. On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases.
    Eur J Immunol. 1989 Apr;19(4):689-94 PMID: 2543584
  31. Production and use of neutralizing monoclonal antibodies to rat interleukin-2.
    Transplant Proc. 1989 Feb;21(1 Pt 1):994-6 PMID: 2650305
  32. Tumor necrosis factor identified in multiple sclerosis brain.
    J Exp Med. 1989 Aug 1;170(2):607-12 PMID: 2754393
  33. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies.
    J Exp Med. 1987 Nov 1;166(5):1229-44 PMID: 2960769
  34. Transforming growth factor beta: biochemistry and roles in embryogenesis, tissue repair and remodeling, and carcinogenesis.
    Recent Prog Horm Res. 1988;44:157-97 PMID: 3064207
  35. Immunoregulatory molecules and IL 2 receptors identified in multiple sclerosis brain.
    J Immunol. 1986 May 1;136(9):3239-45 PMID: 3082983
  36. Interferon-gamma and Ia antigen are present on astrocytes in active chronic multiple sclerosis lesions.
    J Neurol Sci. 1988 Apr;84(2-3):257-64 PMID: 3132537
  37. Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes.
    Biochem Biophys Res Commun. 1987 Dec 16;149(2):755-61 PMID: 3322281
  38. Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen.
    Proc Natl Acad Sci U S A. 1986 Oct;83(19):7443-6 PMID: 3463976
  39. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1.
    Proc Natl Acad Sci U S A. 1986 Jun;83(12):4533-7 PMID: 3487091
  40. Ia expression by vascular endothelium is inducible by activated T cells and by human gamma interferon.
    J Exp Med. 1983 Apr 1;157(4):1339-53 PMID: 6403654
  41. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines.
    Proc Natl Acad Sci U S A. 1987 Dec;84(24):9233-7 PMID: 3480540
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1992-11-01
Pages
1355-64
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2119419
Subset
IM
Grants
PHS HHS · N529352 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com